Advertisement

Der Onkologe

, Volume 24, Issue 12, pp 1009–1014 | Cite as

Chirurgische Therapie im Stadium I und II des nichtkleinzelligen Lungenkarzinoms

  • Laura V. Klotz
  • Hauke WinterEmail author
Leitthema
  • 77 Downloads

Zusammenfassung

Hintergrund

In den vergangenen Jahrzehnten hat sich die Prognose des Lungenkarzinoms trotz moderner Diagnostik und multimodaler Therapiestrategien kaum verbessert. Ein großer Anteil der Patienten mit einem nichtkleinzelligen Lungenkarzinom (NSCLC; 57 %) haben zum Zeitpunkt der Diagnose Fernmetastasen und nur etwa 40 % der Patienten sind in einem potenziell operablen Tumorstadium.

Material und Methoden

Diese Arbeit basiert auf einer selektiven Literaturrecherche in der Datenbank PubMed sowie eigenen Erfahrungen zum Thema des Artikels.

Ergebnisse

Für Patienten in einem frühen Tumorstadium, Stadium I und II nach der Klassifikation der Tumorstadien in der 8. Ausgabe der Union for International Cancer Control (UICC), ist die chirurgische anatomische Tumorresektion in Kombination mit einer systematischen mediastinalen und hilären Lymphknotendissektion das Therapieverfahren der Wahl. Mit dem klassischen Resektionsverfahren der Lobektomie (Bilobektomie, Pneumonektomie) in Verbindung mit einer systematischen Lymphadenektomie lassen sich Fünfjahresüberlebensraten von über 80 % im Frühstadium IA bzw. 48 % im Stadium II erzielen. Neben der offenen chirurgischen Resektion konnten weltweit minimal-invasive, videoassistierte thorakoskopische Resektionsverfahren (VATS, „video-assisted thoracic surgery“) im Stadium I und II erfolgreich etabliert werden. Im Stadium II kann eine adjuvante Chemotherapie das Überleben positiv beeinflussen.

Diskussion

Ob zielgerichtete Krebstherapien (sog. „targeted therapies“) oder eine Immuntherapie im neoadjuvanten oder adjuvanten Therapiekonzept beim NSCLC im Frühstadium das Überleben der Patienten verbessern, wird momentan in Studien untersucht.

Schlüsselwörter

Videoassistierte Thorakoskopie Lobektomie Bilobektomie Pneumonektomie Segmentresektion 

Surgical treatment of stage I and II non-small cell lung cancer

Abstract

Background

Despite modern diagnostics and multimodal treatment strategies, overall survival of lung cancer could not be significantly improved in recent decades. The majority of patients with non-small cell lung cancer (NSCLC) have distant metastases at the time of diagnosis (57%) and only approximately 40% of patients are in a potentially curable tumor stage.

Material and methods

A systematic literature search concerning original research and review articles on surgery of NSCLC in stages I and II was carried out in the PubMed database.

Results

For patients in an early tumor stage, stages I and II tumors according to the 8th edition of the Union for International Cancer Control (UICC) tumor stage classification, surgical removal of the tumor remains the therapeutic gold standard. By complete anatomical resection (lobectomy, bilobectomy or pneumonectomy) combined with a systematic mediastinal and hilar lymphadenectomy, 5‑year survival rates of more than 80% in early stage IA and 48% in stage II can be achieved. In addition to open surgical resection, video-assisted, minimally invasive thoracoscopic (VATS) resection was successfully implemented worldwide for the treatment of NSCLC patients in stages I and II. For patients with stage II NSCLC, adjuvant chemotherapy was shown to improve the overall survival.

Discussion

Whether targeted therapies or immunotherapy in a neoadjuvant or adjuvant treatment modality further improve the survival of NSCLC patients in the multimodal treatment of early stage NSCLC, is currently under investigation in randomized studies.

Keywords

VATS Lobectomy Bilobectomy Pneumonectomy Segmentectomy 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

L.V. Klotz und H. Winter geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Agostini P, Lugg ST, Adams K et al (2017) Postoperative pulmonary complications and rehabilitation requirements following lobectomy: a propensity score matched study of patients undergoing video-assisted thoracoscopic surgery versus thoracotomydagger. Interact Cardiovasc Thorac Surg 24:931–937CrossRefGoogle Scholar
  2. 2.
    Amore D, Di Natale D, Scaramuzzi R et al (2018) Reasons for conversion during VATS lobectomy: what happens with increased experience. J Visc Surg 4:53CrossRefGoogle Scholar
  3. 3.
    Brunelli A, Kim AW, Berger KI et al (2013) Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e166S–e190SCrossRefGoogle Scholar
  4. 4.
    Casiraghi M, Galetta D, Borri A et al (2018) Ten years’ experience in robotic-assisted thoracic surgery for early stage lung cancer. Thorac Cardiovasc Surg.  https://doi.org/10.1055/s-0038-1639575 CrossRefPubMedGoogle Scholar
  5. 5.
    Deng B, Cassivi SD, De Andrade M et al (2014) Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases. J Thorac Cardiovasc Surg 148:1186–1192.e3CrossRefGoogle Scholar
  6. 6.
    Endoh H, Yamamoto R, Satoh Y et al (2013) Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today 43:514–520CrossRefGoogle Scholar
  7. 7.
    Ezer N, Kale M, Sigel K et al (2018) Outcomes after video-assisted thoracoscopic lobectomy versus open lobectomy for early-stage lung cancer in older adults. Ann Am Thorac Soc 15:76–82CrossRefGoogle Scholar
  8. 8.
    Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615–622 (discussion 622–613)CrossRefGoogle Scholar
  9. 9.
    Goldstraw P, Chansky K, Crowley J et al (2016) The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11:39–51CrossRefGoogle Scholar
  10. 10.
    Higuchi M, Yaginuma H, Yonechi A et al (2014) Long-term outcomes after video-assisted thoracic surgery (VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancer. J Cardiothorac Surg 9:88CrossRefGoogle Scholar
  11. 11.
    Kadota K, Villena-Vargas J, Yoshizawa A et al (2014) Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol 38:448–460CrossRefGoogle Scholar
  12. 12.
    Landreneau RJ, Normolle DP, Christie NA et al (2014) Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol 32:2449–2455CrossRefGoogle Scholar
  13. 13.
    Ma Z, Dong A, Fan J et al (2007) Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysis. Eur J Cardiothorac Surg 32:20–28CrossRefGoogle Scholar
  14. 14.
    Mcdonald F, De Waele M, Hendriks LE et al (2017) Management of stage I and II nonsmall cell lung cancer. Eur Respir J 49:1600764.  https://doi.org/10.1183/13993003.00764-2016 CrossRefPubMedGoogle Scholar
  15. 15.
    Meriggi F, Zaniboni A (2006) Non-small-cell lung cancer in the elderly. Crit Rev Oncol Hematol 57:183–190CrossRefGoogle Scholar
  16. 16.
    Mohiuddin K, Haneuse S, Sofer T et al (2014) Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (〈/=2 cm) non-small cell lung cancer. J Thorac Cardiovasc Surg 147:1169–1175 (discussion 1175–1167)CrossRefGoogle Scholar
  17. 17.
    Mulvihill MS, Cox ML, Becerra DC et al (2018) Higher utilization of surgery confers superior survival in stage I non-small cell lung cancer. Ann Thorac Surg.  https://doi.org/10.1016/j.athoracsur.2018.05.066 CrossRefPubMedGoogle Scholar
  18. 18.
    Nakagawa T, Negoro Y, Matsuoka T et al (2014) Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer. Respir Investig 52:221–226CrossRefGoogle Scholar
  19. 19.
    National Lung Screening Trial Research T, Aberle DR, Adams AM et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409CrossRefGoogle Scholar
  20. 20.
    Perez-Ramirez C, Canadas-Garre M, Robles AI et al (2016) Liquid biopsy in early stage lung cancer. Transl Lung Cancer Res 5:517–524CrossRefGoogle Scholar
  21. 21.
    Pilleron S, Sarfati D, Janssen-Heijnen M et al (2018) Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer.  https://doi.org/10.1002/ijc.31664 CrossRefPubMedGoogle Scholar
  22. 22.
    Puri V, Patel A, Majumder K et al (2015) Intraoperative conversion from video-assisted thoracoscopic surgery lobectomy to open thoracotomy: a study of causes and implications. J Thorac Cardiovasc Surg 149:55–61, 62e51CrossRefGoogle Scholar
  23. 23.
    Qu X, Wang K, Zhang T et al (2017) Long-term outcomes of stage I NSCLC (〈/=3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis. J Thorac Dis 9:4561–4573CrossRefGoogle Scholar
  24. 24.
    Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. Ca Cancer J Clin 66:7–30CrossRefGoogle Scholar
  25. 25.
    Tanoue LT, Tanner NT, Gould MK et al (2015) Lung cancer screening. Am J Respir Crit Care Med 191:19–33CrossRefGoogle Scholar
  26. 26.
    Van Leeuwen BL, Huisman MG, Audisio RA (2013) Surgery in older cancer patients—recent results and new techniques: worth the investment? Interdiscip Top Gerontol 38:124–131CrossRefGoogle Scholar
  27. 27.
    Wei S, Chen M, Chen N et al (2017) Feasibility and safety of robot-assisted thoracic surgery for lung lobectomy in patients with non-small cell lung cancer: a systematic review and meta-analysis. World J Surg Oncol 15:98CrossRefGoogle Scholar
  28. 28.
    Weksler B, Nason KS, Shende M et al (2012) Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg 94:889–893CrossRefGoogle Scholar
  29. 29.
    Whitson BA, Andrade RS, Boettcher A et al (2007) Video-assisted thoracoscopic surgery is more favorable than thoracotomy for resection of clinical stage I non-small cell lung cancer. Ann Thorac Surg 83:1965–1970CrossRefGoogle Scholar
  30. 30.
    Whitson BA, Groth SS, Duval SJ et al (2008) Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann Thorac Surg 86:2008–2016 (discussion 2016–2008)CrossRefGoogle Scholar
  31. 31.
    Wolf A, Liu B, Leoncini E et al (2018) Outcomes for thoracoscopy versus thoracotomy not Just technique dependent: a study of 9,787 patients. Ann Thorac Surg 105:886–891CrossRefGoogle Scholar
  32. 32.
    Wolf AS, Richards WG, Jaklitsch MT et al (2011) Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg 92:1819–1823 (discussion 1824–1815)CrossRefGoogle Scholar
  33. 33.
    Wu N, Yan S, Lv C et al (2011) Comparison of systematic mediastinal lymph node dissection versus systematic sampling for lung cancer staging and completeness of surgery. J Surg Res 171:e169–e173CrossRefGoogle Scholar
  34. 34.
    Xue Y, Wang YY, Zhang K et al (2015) A study of complete video-assisted thoracoscopic surgery lobectomy in treatment of elderly patients with non-small cell lung cancer: curative effect and impact on clinical prognosis. Cell Biochem Biophys 73:399–404CrossRefGoogle Scholar
  35. 35.
    Yang CJ, Kumar A, Klapper JA et al (2017) A national analysis of long-term survival following thoracoscopic versus open Lobectomy for stage I non-small-cell lung cancer. Ann Surg.  https://doi.org/10.1097/sla.0000000000002342 CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Zhang Y, Sun Y, Wang R et al (2015) Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer. J Surg Oncol 111:334–340CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Abteilung Thoraxchirurgie, ThoraxklinikUniversitätsklinikum HeidelbergHeidelbergDeutschland

Personalised recommendations